1Reiter R E，Proc Nat Acad Sci SUA，1998年，95卷，4期，1735页
2Lein M，Urology，1998年，37卷，4期，377页
同被引文献10
1Yaman O, Gogus C, Tulunay O, et al. Increased prostate specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation. Urol Int 2003; 71(2): 160-164
2Bauer JJ, Zeng J, Weir J, et al. Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology 1999; 53(5): 961-967
3Villers A, Mouton D, Rebillard X, et al. Biopsy technique and biopsy schemes for a first series of prostatic biopsies. Prog Urol 2004; 14(2): 144-153
4Ng TK, Vasilareas D, Mitterdorfer AJ, et al. Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice. BJU Int 2005; 95(4): 545-548
5Murphy GP,Barren RJ,Erickson SJ,et al.Evaluation and cooperation of two new prostate carcinoma markers.Free-prostate specific antigen and prostate specific membrane antigen.Cancer,1996,78:809-818.
6Prestigiacoma AF,Lilja H,Petterson K,et al.A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates:the best case scenario.J Urol,1996,156:350-354.
7Yao SL,Humphrey PA.Understanding and appreciating overdiagnosis in the PSA era.J Natl Cancer Inst,2002,94:958-960.
